OncoSec Medical Inc. (ONCS) to Release Quarterly Earnings on Thursday
OncoSec Medical Inc. (NASDAQ:ONCS) is scheduled to be issuing its Q416 quarterly earnings data on Thursday, October 13th. Analysts expect the company to announce earnings of ($0.35) per share for the quarter.
Shares of OncoSec Medical Inc. (NASDAQ:ONCS) opened at 1.72 on Wednesday. The firm’s market cap is $30.33 million. OncoSec Medical Inc. has a 12-month low of $1.36 and a 12-month high of $4.61. The stock’s 50 day moving average is $1.72 and its 200-day moving average is $1.84.
A number of equities research analysts have commented on ONCS shares. Rodman & Renshaw started coverage on shares of OncoSec Medical in a report on Thursday, July 21st. They set a “buy” rating and a $6.00 price objective on the stock. Maxim Group lowered shares of OncoSec Medical to a “buy” rating and reduced their target price for the company from $17.00 to $5.00 in a research note on Thursday, July 21st.
A hedge fund recently raised its stake in OncoSec Medical stock. Vanguard Group Inc. raised its stake in shares of OncoSec Medical Inc. (NASDAQ:ONCS) by 3.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 430,031 shares of the company’s stock after buying an additional 13,025 shares during the period. Vanguard Group Inc. owned 2.44% of OncoSec Medical worth $705,000 at the end of the most recent quarter. Institutional investors own 7.42% of the company’s stock.
About OncoSec Medical
OncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. The Company’s portfolio includes biologic immunology therapeutic product candidates intended to treat a range of tumor types.
Receive News & Stock Ratings for OncoSec Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical Inc. and related stocks with our FREE daily email newsletter.